Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 29.765% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a) CCOc1ccc(OCC)c(NC(=O)C2CCCN(S(=O)(=O)c3cnc[nH]3)C2)c1
b) COC(=O)c1ccc(CSc2nnc(NC(C)C)s2)o1
c) COc1cc(-c2nnc(SCC(=O)OC3CCCCC3)o2)cc(OC)c1OC
Answer: b. COC(=O)c1ccc(CSc2nnc(NC(C)C)s2)o1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COC(=O)c1ccc(CSc2nnc(NC(C)C)s2)o1
COC(=O)c1ccc(CSc2nnc(NC(C)C)s2)o1
methyl 5-[[5-(propan-2-ylamino)-1,3,4-thiadiazol-2-yl]sulfanylmethyl]furan-2-carboxylate